Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model

Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model

Background Therapeutic drug monitoring (TDM) of Vancomycin (VCM) is required to prevent inappropriate dosage-associated bacterial resistance, therapeutic failure, and toxicities in pediatrics. Anecdotal experience and studies show that many healthcare institutions confront barriers while implementin...

Full description

Bibliographic Details
Main Authors:	Kashif Hussain, Rahila Ikram, Gul Ambreen, Muhammad Sohail Salat
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-12-01
Series:	Journal of Pharmaceutical Policy and Practice
Subjects:	therapeutic drug monitoring pharmacist vancomycin pediatric tdm
Online Access:	http://dx.doi.org/10.1186/s40545-021-00383-y

Similar Items

Bridging the Gap between Theory and Practice; the Active Role of Inpatient Pharmacists in Therapeutic Drug Monitoring
by: Abrar F Alhameed, et al.
Published: (2019-02-01)

Practical approaches to improve vancomycin-related patient outcomes in pediatrics- an alternative strategy when AUC/MIC is not feasible
by: Kashif Hussain, et al.
Published: (2022-08-01)

The Development, Implementation, and Evaluation of a Pharmacist-Managed Therapeutic Drug Monitoring (TDM) Service for Vancomycin—A Pilot Study
by: Paul Firman, et al.
Published: (2022-12-01)

Prediction of vancomycin initial dosage using artificial intelligence models applying ensemble strategy
by: Wen-Hsien Ho, et al.
Published: (2023-03-01)

A descriptive study of vancomycin use at Red Cross War Memorial Children’s Hospital, Cape Town
by: Leonore Greybe, et al.
Published: (2023-11-01)

Vancomycin Prescribing Practices and Therapeutic Drug Monitoring for Critically Ill Neonatal and Pediatric Patients: A Survey of Physicians and Pharmacists in Hong Kong
by: Twinny Cheuk Hin Chow, et al.
Published: (2020-11-01)

Impact of Pharmacist-Led Multidisciplinary Team to Attain Targeted Vancomycin Area under the Curved Monitoring in a Tertiary Care Center in Thailand
by: Kittiya Jantarathaneewat, et al.
Published: (2023-02-01)

Real-Life Vancomycin Therapeutic Drug Monitoring in Coagulase-Negative Staphylococcal Bacteremia in Neonatal and Pediatric Intensive Care Unit: Are We Underestimating Augmented Renal Clearance?
by: Claudia Sette, et al.
Published: (2023-10-01)

Is vancomycin monitoring of real value in pediatric cancer patients?
by: Mohamed S. Imam, et al.
Published: (2018-03-01)

Pharmacokinetic assessment of vancomycin in critically ill patients and nephrotoxicity prediction using individualized pharmacokinetic parameters
by: Parisa Ghasemiyeh, et al.
Published: (2022-08-01)

Experience of Vancomycin Therapeutic Drug Monitoring in Two Multidisciplinary Hospitals in Latvia
by: Inga Mauliņa, et al.
Published: (2022-03-01)

Therapeutic Drug Monitoring of Quinidine in Pediatric Patients with <i>KCNT1</i> Genetic Variants
by: Alessandro Ferretti, et al.
Published: (2022-10-01)

A machine learning model that emulates experts’ decision making in vancomycin initial dose planning
by: Tetsuo Matsuzaki, et al.
Published: (2022-04-01)

Therapeutic drug monitoring of vancomycin in an obese patient with renal insufficiency
by: Said Abuhasna, et al.
Published: (2011-01-01)

Recent Advances in Therapeutic Drug Monitoring of Voriconazole, Mycophenolic Acid, and Vancomycin: A Literature Review of Pediatric Studies
by: Matylda Resztak, et al.
Published: (2021-11-01)

Comparison of vancomycin serum levels prior to and post therapeutic drug monitoring in patients admitted to hospital
by: Kaveh Eslami, et al.
Published: (2021-09-01)

A simple and validated HPLC method for vancomycin assay in plasma samples: the necessity of TDM center development in Southern Iran
by: Parisa Ghasemiyeh, et al.
Published: (2020-01-01)

Therapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients
by: Dae Il Kim, et al.
Published: (2010-12-01)

A rapid and simple HPLC-MS/MS method for the therapeutic drug monitoring of six special-grade antimicrobials in pediatric patients
by: Xijuan Jiang, et al.
Published: (2024-01-01)

Pharmacokinetics and therapeutic target attainment of vancomycin in pediatric post-liver transplant patients
by: Ronaldo Morales Junior, et al.
Published: (2023-11-01)

Clinical Response and Hospital Costs of Therapeutic Drug Monitoring for Vancomycin in Elderly Patients
by: Yun Kim, et al.
Published: (2022-01-01)

Extremely high levels of vancomycin can cause severe renal toxicity
by: Barceló-Vidal J, et al.
Published: (2018-07-01)

Evaluation of the Association between Trough and Area Under the Curve to Minimum Inhibitory Concentration Ratio (AUC24/MIC) of Vancomycin in Infected Patients with Methicillin Resistant Staphylococcus aureus (MRSA)
by: Ayda Esmaeili, et al.
Published: (2021-06-01)

Assessment of Initial Vancomycin Dosing in Pediatric Oncology Patients
by: Hillary Orr, et al.
Published: (2017-08-01)

Bayesian method application: Integrating mathematical modeling into clinical pharmacy through vancomycin therapeutic monitoring
by: Ashley Chen, et al.
Published: (2022-12-01)

Therapeutic drug monitoring of vancomycin in patients with infectious complications in traumatology and orthopedics
by: Borisov A.M., et al.
Published: (2020-03-01)

Is There a Role for the Therapeutic Drug Monitoring of Colistin? An Overview
by: Maria-Paula Avila, et al.
Published: (2020-03-01)

Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant Staphylococcus aureus infections: a single institution experience
by: Hirano R, et al.
Published: (2016-10-01)

Evaluation of Real-World Vancomycin Dosing and Attainment of Therapeutic Drug Monitoring Targets
by: Nicole Bradley, et al.
Published: (2023-06-01)

Drug Utilization Evaluation of Vancomycin in Pediatric Department
by: Farzaneh Dehghan, et al.
Published: (2018-01-01)

Monitoring of Serum Vancomycin Concentrations in Pediatric Patients with Normal Renal Function
by: Ghamar Taj Khotaei, et al.
Published: (2010-03-01)

Monitoring of Serum Vancomycin Concentrations in Pediatric Patients with Normal Renal Function
by: Ghamar Taj Khotaei, et al.
Published: (2010-04-01)

Clinical Application Value of Pharmacokinetic Parameters of Vancomycin in Children Treated in the Pediatric Intensive Care Unit
by: Bo Zhou, et al.
Published: (2022-06-01)

Therapeutic drug monitoring of lacosamide among children: is it helpful?
by: Elkana Kohn, et al.
Published: (2023-07-01)

What Is the Best Vancomycin Therapeutic Drug Monitoring Parameter to Assess Efficacy? A Critical Review of Experimental Data and Assessment of the Need for Individual Patient Minimum Inhibitory Concentration Value
by: Bruce R. Dalton
Published: (2023-02-01)

Vancomycin Dosage and Its Association with Clinical Outcomes in Pediatric Patients with Gram-Positive Bacterial Infections
by: Shin S, et al.
Published: (2020-06-01)

Population pharmacokinetics of gentamicin in acute lymphoblastic leukemia pediatric patients compared to non-oncology patients
by: Hisham S. Abou-Auda, et al.
Published: (2024-05-01)

Clinical application of vancomycin TDM in ventilated patients with gastrointestinal cancer: a propensity-matched analysis
by: Xiaowu Zhang, et al.
Published: (2024-01-01)

Personalized Medicine for Antibiotics: The Role of Nanobiosensors in Therapeutic Drug Monitoring
by: Vivian Garzón, et al.
Published: (2020-09-01)

Vancomycin Therapeutic Drug Monitoring (TDM) and Its Association with Clinical Outcomes: A Retrospective Cohort
by: Juhaina Salim Al-Maqbali, et al.
Published: (2022-05-01)